secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2022-05-16T23:59:59+00:00
Accession:  0001077183-22-000085
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics appoints Lynn Tetrault as Interim CEO; Chief Strategy Officer departing May 27
--------------------------------------------------------------------------------

- Lynn Tetrault named Chair of the Board and Interim CEO, effective May 12, 2022; no compensation change.
- Company disbands Interim Office of the CEO; Tetrault previously served as Executive Chair since March.
- Board's external search for permanent CEO is 'on track' per Lead Independent Director Michael Kelly.
- Chief Strategy and Corporate Development Officer Douglas Brown leaves May 27 to pursue other interests.
- CFO William Bonello and Chief Culture Officer Jennifer Balliet remain in their roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000085/0001077183-22-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000085/neo-20220512.htm
  HTML page:      https://secwatch.observer/filing/0001077183-22-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer